T2DM drug classes and individual agents within each class
| DPP4 inhibitors | GLP1 receptor antagonists | SGLT2 inhibitors | Sulfonylureas |
| Alogliptin | Albiglutide | Canagliflozin | Chlorpropamide |
| Linagliptin | Dulaglutide | Dapagliflozin | Glimepiride |
| Saxagliptin | Exenatide | Empagliflozin | Glipizide |
| Sitagliptin | Liraglutide | Ertugliflozin | Gliquidone |
| Vildagliptin | Lixisenatide | Glyburide | |
| Semaglutide | Tolazamide | ||
| Tolbutamide |
DPP4, dipeptidyl peptidase-4; GLP1, glucagon-like peptide-1; SGLT2, sodium–co-transporter-2; T2DM, type 2 diabetes mellitus.